Inhibrx Biosciences, Inc. INBX Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets?
- Inhibrx Biosciences, Inc. (INBX) reported increase (decrease) in prepaid expense and other assets of $1.06M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Inhibrx Biosciences, Inc.'s increase (decrease) in prepaid expense and other assets increased by 245.6% year-over-year, from -$730K to $1.06M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.